Progress in muscle research through the international congress of neuromuscular diseases (ICNMD): a narrative review
HTML: 5
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Progress in muscle research has been through different phases over the past decades. Here are reviewed the advances presented at the International Congresses of Neuromuscular Diseases (ICNMD). In the ‘60 to ‘80 muscle physiology and interpretations of muscle biopsy were the major focuses, diagnosis of muscle disorders was advanced utilizing histochemical, and ultrastructural techniques, and the focus of first to IVth ICNMD was prevention and Muscle Disorders classification as major issues. After that from ‘80 to 2000 muscle neuromuscular junction (NMJ) immunology, biochemistry, molecular biology , therapeutic trials, and genetics were the major developments and represented the focus of research in following ICNMD from the Vth to the Xth. From 2000 to 2020 personalized medicine,genotype-phenotype correlation, and the use of DNA/RNA profiling , Imaging was developed and represented substantial signs of progress that were presented in ICNMD XIth to XVIIth. The future is evolving toward a major involvement of the pharmaceutical industry with new drugs and gene-delivered therapy, the use of biomarkers and robotics as well as of artificial intelligence, both for interpreting morphology, DNA, and imaging diagnostic, and such developments will be reflected in research presented in future Congresses.
Angelini C. Advances and Perspectives in Muscular Dystrophies. Basic Appl Myol. 2002;12(1):17-25.
IV International Congress on Neuromuscular Diseases. Abstract. Queen Elizabeth Hotel, Montreal Canada, 1978.
Serratrice G, Cros D, Desnuelle C, Gastaut JL, Pelissier JF, Pouget J, Schiano A. Neuromuscular Diseases. Raven Press; 1984. DOI: https://doi.org/10.1097/00005072-198409000-00009
Abstracts of invited speakers and chairmen and submitted abstracts VI International Congress on Neuromuscular Diseases. Muscle & Nerve 1986;9No5S, Supplement.
VII International Congress on Neuromuscular Diseases. 16-22 September 1990, Munich, Federal Republic of Germany. Abstracts. J Neurol Sci. 1990 Sep;98 Suppl:1-527. PMID: 1976764.
Angelini C, Danieli GA, Fontanari D. Muscular Dystrophy Research, from molecular diagnosis toward therapy, Excerpta Medica, International Congress Series, 134 Amsterdam, New York, Oxford, 1991.
International Symposium on Glycolytic and Mitochondrial Defects in Muscle and Nerve. Osaka, Japan, July 7-8, 1994. Muscle Nerve Suppl. 1995;3:S1-174. PMID: 7603507.
Abstracts of the Xth International Congress on Neuromuscular Diseases. 7-12 July 2002, Vancouver, Canada. J Neurol Sci. 2002 Jul 15;199 Suppl 1:S1-136. PMID: 12530409.
XII International Congress on Neuromuscular Diseases. Acta Myologica 2010; 29, 25-315.
Abstracts of the 13th ICNMD. J Neuromuscul Diseases 2014;1,Suppl ement 1.
Abstracts of the 14th ICNMD. J Neuromuscul Diseases 2016;3,Supplement 1.
15th International Congress on Neuromuscular Diseases, July 6 - 10, 2018 Vienna, Austria. J Neuromuscul Dis. 2018 Jun 25;5(Suppl 1):S1–S408. PMCID: PMC6027950. DOI: https://doi.org/10.3233/JND-189001
Angelini C, Pinzan E. Advances in imaging of brain abnormalities in neuromuscular disease. Ther Adv Neurol Disord. 2019 May 6;12:1756286419845567. PMID: 31105770; PMCID: PMC6503605. DOI: https://doi.org/10.1177/1756286419845567
Angelini C.Abstracts of the 17thICNMD J Neuromuscul Diseases 2022,9 (Suppl 1) :S38-S39 .
Angelini C, Di Mauro S, Margreth A. Relationship of serum enzymes changes to muscle damage in vitamin E deficiency of the rabbit. Lo Sperimentale 1968;118 (5):349-69
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.